MDM2在去分化脂肪肉瘤诊断与治疗中的新作用。 - Suppr

The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcoma.

作者信息

Ichikawa Jiro, Kawasaki Tomonori, Onohara Kojiro, Kanno Satoshi, Wako Masanori, Ochiai Satoshi, Aoki Kaoru, Haro Hirotaka

机构信息

Department of Orthopaedic Surgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.

Department of Pathology, Saitama Medical University International Medical Center, Kawagoe, Saitama, Japan.

出版信息

Front Oncol. 2024 Oct 18;14:1466399. doi: 10.3389/fonc.2024.1466399. eCollection 2024.

DOI:10.3389/fonc.2024.1466399

PMID:39493445

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11527593/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fbb/11527593/21a21a3c88c3/fonc-14-1466399-g001.jpg

相似文献

The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcoma.MDM2在去分化脂肪肉瘤诊断与治疗中的新作用。

Front Oncol. 2024 Oct 18;14:1466399. doi: 10.3389/fonc.2024.1466399. eCollection 2024.

Challenging dedifferentiated liposarcoma identified by MDM2-amplification, a report of two cases.通过MDM2扩增鉴定出的具有挑战性的去分化脂肪肉瘤：两例报告

BMC Clin Pathol. 2014 Jul 28;14:36. doi: 10.1186/1472-6890-14-36. eCollection 2014.

Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.非典型脂肪瘤样肿瘤/高分化脂肪肉瘤与去分化脂肪肉瘤的鉴别诊断：p16联合MDM2和CDK4免疫组化的应用价值

Hum Pathol. 2017 Jan;59:34-40. doi: 10.1016/j.humpath.2016.08.009. Epub 2016 Sep 3.

Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.法国国立癌症中心分级及MDM2扩增水平在去分化脂肪肉瘤中的预后相关性：一项50例病例的研究

Mod Pathol. 2015 Jan;28(1):37-47. doi: 10.1038/modpathol.2014.88. Epub 2014 Jul 25.

Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.MDM2荧光原位杂交和免疫组织化学在鉴别去分化脂肪肉瘤与其他高级别肉瘤中的应用

Appl Immunohistochem Mol Morphol. 2017 Nov/Dec;25(10):712-719. doi: 10.1097/PAI.0000000000000365.

Primary extraskeletal osteosarcoma: a clinicopathological study of 18 cases focusing on MDM2 amplification status.原发性骨外骨肉瘤：18例临床病理研究，重点关注MDM2扩增状态

Hum Pathol. 2017 May;63:63-69. doi: 10.1016/j.humpath.2017.02.007. Epub 2017 Feb 22.

Ultrasound-guided fine-needle aspiration of a posterior neck dedifferentiated liposarcoma with MDM2 fluorescence in situ hybridization performed on a Pap-stained smear.超声引导下对颈部后方去分化脂肪肉瘤进行细针穿刺抽吸，并在巴氏染色涂片上进行MDM2荧光原位杂交。

Diagn Cytopathol. 2015 Apr;43(4):320-4. doi: 10.1002/dc.23200. Epub 2014 Jul 31.

The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.荧光原位杂交（FISH）在确定去分化脂肪肉瘤中DNA损伤诱导转录物3（DDIT3）扩增方面的效用——一个重要的诊断陷阱。

Pathol Res Pract. 2021 Sep;225:153555. doi: 10.1016/j.prp.2021.153555. Epub 2021 Jul 21.

[Dedifferentiated liposarcoma of extremities: a clinicopathologic analysis].[肢体去分化脂肪肉瘤：临床病理分析]

Zhonghua Bing Li Xue Za Zhi. 2018 Jul 8;47(7):511-516. doi: 10.3760/cma.j.issn.0529-5807.2018.07.006.

Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma.检测MDM2基因扩增或蛋白表达可将硬化性肠系膜膜炎和腹膜后纤维化与炎症性高分化脂肪肉瘤区分开来。

Mod Pathol. 2009 Jan;22(1):66-70. doi: 10.1038/modpathol.2008.153. Epub 2008 Oct 3.

引用本文的文献

Imaging and histopathological considerations in determining the primary site and differential diagnosis of gallbladder liposarcoma.确定胆囊脂肪肉瘤原发部位及鉴别诊断时的影像学和组织病理学考量

World J Surg Oncol. 2025 Jul 1;23(1):256. doi: 10.1186/s12957-025-03915-x.

本文引用的文献

Use of Mitotic Activity and the Size of Any Dedifferentiated Component for Risk Assessment in MDM2-Amplified Liposarcoma.在MDM2扩增的脂肪肉瘤中使用有丝分裂活性和任何去分化成分的大小进行风险评估。

Arch Pathol Lab Med. 2025 May 1;149(5):422-430. doi: 10.5858/arpa.2024-0098-OA.

Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment.细胞周期蛋白依赖性激酶4（CDK4）作为软组织肉瘤预后生物标志物的作用及其抑制在去分化脂肪肉瘤序贯治疗中的协同效应

Exp Hematol Oncol. 2024 Aug 5;13(1):74. doi: 10.1186/s40164-024-00540-4.

A Rare Case of Dedifferentiated Liposarcoma with Osteosarcomatous Differentiation-Diagnostic and Therapeutic Challenges.一例罕见的具有骨肉瘤分化的去分化脂肪肉瘤——诊断与治疗挑战

Diseases. 2023 Dec 25;12(1):6. doi: 10.3390/diseases12010006.

Imaging presentation of extraskeletal osteosarcomas on CT and MRI and correlation with patients outcome: A two-center retrospective study of 54 patients.骨外骨肉瘤的 CT 和 MRI 影像学表现及其与患者预后的相关性：54 例患者的两项中心回顾性研究。

Diagn Interv Imaging. 2023 Jun;104(6):297-306. doi: 10.1016/j.diii.2023.01.009. Epub 2023 Feb 21.

The Characteristics of magnetic resonance imaging and immunohistochemical findings in de-differentiated liposarcoma.去分化脂肪肉瘤的磁共振成像和免疫组织化学特征。

J Orthop Surg (Hong Kong). 2023 Jan-Apr;31(1):10225536231151519. doi: 10.1177/10225536231151519.

FISH Diagnostic Assessment of Amplification in Liposarcoma: Potential Pitfalls and Troubleshooting Recommendations.FISH 诊断脂肪肉瘤扩增：潜在陷阱和故障排除建议。

Int J Mol Sci. 2023 Jan 10;24(2):1342. doi: 10.3390/ijms24021342.

Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.原发性腹膜后肉瘤患者的术前放疗：EORTC-62092 试验（STRASS）与非试验（STREXIT）结果。

Ann Surg. 2023 Jul 1;278(1):127-134. doi: 10.1097/SLA.0000000000005492. Epub 2022 Jul 14.

Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/ well differentiated liposarcoma.在一部分非典型性脂肪肉瘤/高分化脂肪肉瘤中，MDM2/CDK4 免疫组化阴性不能完全排除 MDM2/CDK4 扩增。

Pathol Res Pract. 2022 Apr;232:153839. doi: 10.1016/j.prp.2022.153839. Epub 2022 Mar 11.

Dedifferentiated Liposarcoma: Systemic Therapy Options.去分化脂肪肉瘤：系统治疗选择。

Curr Treat Options Oncol. 2020 Feb 5;21(2):15. doi: 10.1007/s11864-020-0705-7.

Prognostic Value of Myogenic Differentiation in Dedifferentiated Liposarcoma.去分化脂肪肉瘤中肌源性分化的预后价值。

Am J Surg Pathol. 2020 Jun;44(6):799-804. doi: 10.1097/PAS.0000000000001436.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献